Cetera Investment Advisers
COLL icon

Cetera Investment Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Cetera Investment Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Buy
12,706
+2,471
+24% +$84.4K ﹤0.01% 3786
2026
Q1 		$338K Sell
10,235
-32
-0.3% -$1.35K ﹤0.01% 3878
2025
Q4 		$475K Sell
10,267
-418
-4% -$17.5K ﹤0.01% 3486
2025
Q3 		$374K Buy
+10,685
New +$371K ﹤0.01% 3631

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Cetera Investment Advisers's COLL Position: Q2 2026 in Review

Cetera Investment Advisers increased its Collegium Pharmaceutical (COLL) stake by 24% in Q2 2026, buying an estimated $84.4K and bringing the position to 12,706 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3786.

Cetera Investment Advisers first reported a position in COLL in Q3 2025 and has held it in 4 quarters since. The position peaked at $475K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Cetera Investment Advisers held 12,706 shares of Collegium Pharmaceutical worth $460K as of Q2 2026.
  • Cetera Investment Advisers bought 2,471 Collegium Pharmaceutical shares in Q2 2026, an estimated $84.4K.
  • Collegium Pharmaceutical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3786 holding.
  • Cetera Investment Advisers first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Collegium Pharmaceutical position peaked at $475K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.